) has been revised to $10.20 / share. This is an increase of 11.11% from the prior estimate of $9.18 dated November 7, 2025. The price target is an average of many targets provided by analysts. The ...

AMIT KUMAR, the Chief Executive Officer of $ANIX, bought 10,000 shares of the company on 06-04-2025 for an estimated $28,500. This trade was reported by Quiver ...

Anixa Biosciences ANIX shares gained 13% on Wednesday following the announcement that the U.S. Patent and Trademark Office has issued a new patent for its groundbreaking breast cancer vaccine ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." ...